Cited by 26Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchGenetic Associations and Epidemiology

A Brief Synopsis on the Genetics of Alzheimer’s Disease

Open access
Kamboh, M. Ilyas·2018·Current Genetic Medicine Reports

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s40142-018-0155-8

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several known AD susceptibility genes associated with late-onset AD have been linked to alterations in peripheral immune cell function rather than microglial activation.

    “Notably, several of the known AD susceptibility genes that are associated with late-onset AD have been linked to alterations in peripheral immune cell function rather than microglial activation.20,21”

    From TET2-mutant myeloid cells mitigate Alzheimer’s disease progression via CNS infiltration and enhanced phagocytosis in mice (2025) · cites this paper as [21]

    The main text and Table 1 (page unavailable) identify several susceptibility genes for late-onset AD. They do not link those genes to altered peripheral immune cell function rather than microglial activation; a reference title instead mentions microglial-mediated innate immunity. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Research works printed but not linked: 20

  1. [1]Alzheimer’s Association Report 2015 Alzheimer’s disease facts and figures Alzheimers Dement 2015 11 332 384 10.1016/j.jalz.2015.02.003 25984581 · DOI
  2. [2]Zhu XC Tan L Wang HF Jiang T Cao L Wang C Wang J Tan CC Meng XF Yu JT Rate of early onset Alzheimer’s disease: a systematic review and meta-analysis Ann Transl Med 2015 3 38 25815299 PMC4356853
  3. [3]Jarmolowicz AI Chen HY Panegyres PK The patterns of inheritance in early-onset dementia: Alzheimer’s disease and frontotemporal dementia Am J Alzheimers Dis Other Demen 2015 30 299 306 10.1177/1533317514545825 25147204 PMC10852564 · DOI
  4. [5]Gatz M Reynolds CA Fratiglioni L Johansson B Mortimer JA Berg S Fiske A Pedersen NL Role of genes and environments for explaining Alzheimer disease Arch Gen Psychiatry 2006 63 168 174 10.1001/archpsyc.63.2.168 16461860 · DOI · Paper page
  5. [6]Lambert JC Ibrahim-Verbaas CA Harold D Naj AC Sims R Bellenguez C Gyungah J DeStefano A Bis JC Beecham GW Extended meta-analysis of 74,538 individuals identifies 11 new susceptibility loci for Alzheimer’s disease Nat Genet 2013 45 152 1458 10.1038/ng.2802 PMC3896259 24162737 · DOI · Paper page
  6. [7]Kunkle BW, Grenier-Boley SR, Bis JC, Naj AC, Boland A, Vronskaya M, et al. Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing. bioRxiv. preprint first posted online Apr. 4, 2018. 10.1101/294629. · DOI · Paper page
  7. [9]Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1,CD33 and CD2AP are associated with Alzheimer’s disease. Nat Genet. 2011;43:429–35. PMC3084173 21460840
  8. [10]Mez J Chung J Jun G Kriegel J Bourlas AP Sherva R Logue MW Barnes LL Bennett DA Buxbaum JD Byrd GS Crane PK Ertekin-Taner N Evans D Fallin MD Foroud T Goate A Graff-Radford NR Hall KS Kamboh MI Kukull WA Larson EB Manly JJ Alzheimer's Disease Genetics Consortium Haines JL Mayeux R Pericak-Vance MA Schellenberg GD Lunetta KL Farrer LA Two novel loci, COBL and SLC10A2, for Alzheimer’s disease in African Americans Alzheimers Dement 2017 13 119 129 10.1016/j.jalz.2016.09.002 27770636 PMC5318231 · DOI
  9. [11]Jun GR Chung J Mez J Barber R Beecham GW Bennett DA Buxbaum JD Byrd GS Carrasquillo MM Crane PK Cruchaga C de Jager P Ertekin-Taner N Evans D Fallin MD Foroud TM Friedland RP Goate AM Graff-Radford NR Hendrie H Hall KS Hamilton-Nelson KL Inzelberg R Kamboh MI Kauwe JSK Kukull WA Kunkle BW Kuwano R Larson EB Logue MW Manly JJ Martin ER Montine TJ Mukherjee S Naj A Reiman EM Reitz C Sherva R St. George-Hyslop PH Thornton T Younkin SG Vardarajan BN Wang LS Wendlund JR Winslow AR Haines J Mayeux R Pericak-Vance MA Schellenberg G Lunetta KL Farrer LA Adams PM Albert MS Albin RL Apostolova LG Arnold SE Asthana S Atwood CS Barmada MM Barnes LL Beach TG Becker JT Bigio EH Bird TD Blacker D Boeve BF Bowen JD Boxer A Burke JR Cairns NJ Cao C Carlson CS Carlsson CM Carney RM Carrasquillo MM Carroll SL Chui HC Clark DG Corneveaux J Cribbs DH Crocco EA Cruchaga C de Jager PL DeCarli C DeKosky ST Demirci FY Dick M Dickson DW Doody RS Duara R Ertekin-Taner N Faber KM Fairchild TJ Fallon KB Farlow MR Ferris S Frosch MP Galasko DR Gearing M Geschwind DH Ghetti B Gilbert JR Glass JD Graff-Radford NR Green RC Growdon JH Hakonarson H Hamilton RL Hardy J Harrell LE Head E Honig LS Huebinger RM Huentelman MJ Hulette CM Hyman BT Jarvik GP Jicha GA Jin LW Karydas A Kauwe JSK Kaye JA Kim R Koo EH Kowall NW Kramer JH LaFerla FM Lah JJ Leverenz JB Levey AI Li G Lieberman AP Lin CF Lopez OL Lyketsos CG Mack WJ Marson DC Martiniuk F Mash DC Masliah E McCormick WC McCurry SM McDavid AN McKee AC Mesulam M Miller BL Miller CA Miller JW Morris JC Mukherjee S Murrell JR Myers AJ O'Bryant S Olichney JM Pankratz VS Parisi JE Partch A Paulson HL Perry W Peskind E Petersen RC Pierce A Poon WW Potter H Quinn JF Raj A Raskind M Reisberg B Reisch JS Reitz C Ringman JM Roberson ED Rogaeva E Rosen HJ Rosenberg RN Royall DR Sager MA Sano M Saykin AJ Schneider JA Schneider LS Seeley WW Smith AG Sonnen JA Spina S Stern RA Tanzi RE Thornton-Wells TA Trojanowski JQ Troncoso JC Tsuang DW van Deerlin VM van Eldik LJ Vardarajan BN Vinters HV Vonsattel JP Weintraub S Welsh-Bohmer KA Williamson J Wishnek S Woltjer RL Wright CB Wu CK Yu CE Yu L Zhang X Transethnic genome-wide scan identifies novel Alzheimer’s disease loci Alzheimers Dement 2017 13 727 738 10.1016/j.jalz.2016.12.012 28183528 PMC5496797 · DOI · Paper page
  10. [12]Jun G Ibrahim-Verbaas CA Vronskaya M Lambert JC Chung J Naj AC Kunkle BW Wang LS Bis JC Bellenguez C A novel Alzheimer disease locus located near the gene encoding tau protein Mol Psychiatry 2016 21 108 1017 10.1038/mp.2015.23 25778476 PMC4573764 · DOI · Paper page
  11. [13]Liu JZ Erlich Y Pickrell JK Case-control association mapping by proxy using family history of disease Nat Genet 2017 49 325 331 10.1038/ng.3766 28092683 · DOI · Paper page
  12. [14]Ruiz A Heilmann S Becker T Hernández I Wagner H Thelen M Mauleón A Rosende-Roca M Bellenguez C Bis JC Follow-up of loci from the international genomics of Alzheimer’s disease project identifies TRIP4 as a novel susceptibility gene Transl Psychiatry 2014 4 e358 10.1038/tp.2014.2 24495969 PMC3944635 · DOI · Paper page
  13. [15]Ridge PG Hoyt KB Boehme K Mukherjee S Crane PK Haines JL Mayeux R Farrer LA Pericak-Vance MA Schellenberg GD Kauwe JSK Alzheimer’s Disease Genetics Consortium (ADGC). Assessment of the genetic variance of late-onset Alzheimer’s disease Neurobiol Aging 2016 200 e13 e20 PMC4948179 27036079
  14. [17]Guerreiro R Wojtas A Bras J Carrasquillo M Rogaeva E Majounie E Cruchaga C Sassi C Kauwe JS Younkin S Hazrati L Collinge J Pocock J Lashley T Williams J Lambert JC Amouyel P Goate A Rademakers R Morgan K Powell J St George-Hyslop P Singleton A Hardy J Alzheimer Genetic Analysis Group TREM2 variants in Alzheimer’s disease N Engl J Med 2013 368 117 127 10.1056/NEJMoa1211851 23150934 PMC3631573 · DOI · Paper page
  15. [20]Jakobsdottir J van der Lee SJ Bis JC Chouraki V Li-Kroeger D Yamamoto S Rare functional variant in TM2D3 is associated with late-onset Alzheimer’s disease PLoS Genet 2016 12 e1006327 10.1371/journal.pgen.1006327 27764101 PMC5072721 · DOI
  16. [21]Li Q Wang BL Sun FR Li JQ Cao XP Tan L The role of UNC5C in Alzheimer’s disease Ann Transl Med. 2018 6 178 10.21037/atm.2018.04.43 29951500 PMC5994511 · DOI
  17. [22]Logue MW Schu M Vardarajan BN Farrell J Bennett DA Buxbaum JD Byrd GS Ertekin-Taner N Evans D Foroud T Goate A Graff-Radford NR Kamboh MI Kukull WA Manly JJ Haines JL Mayeux R Pericak-Vance MA Schellenberg GD Lunetta KL Baldwin CT Fallin MD Farrer LA Two rare AKAP9 variants are associated with Alzheimer’s disease in African Americans Alzheimers Dement 2014 10 609 618 10.1016/j.jalz.2014.06.010 25172201 PMC4253055 · DOI · Paper page
  18. [23]Bis JC, Jian X, Kunkle BW, Chen Y, Hamilton-Nelson KL, Bush WS, et al. Whole exome sequencing study identifies novel rare and common Alzheimer’s-associated variants involved in immune response and transcriptional regulation. Mol Psychiatry. 2018. 10.1038/s41380-018-0112-7. PMC6375806 30108311 · DOI · Paper page
  19. [24]Kim M Suh J Romano D Truong MH Mullin K Hooli B Norton D Tesco G Elliott K Wagner SL Moir RD Becker KD Tanzi RE Potential late-onset Alzheimer’s disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity Hum Mol Genet 2009 18 3987 3996 10.1093/hmg/ddp323 19608551 PMC2748890 · DOI · Paper page
  20. [25]International Genomics of Alzheimer’s Disease Consortium (IGAP) Convergent genetic and expression data implicate immunity in Alzheimer’s disease Azheimers Dement 2015 11 658 671 10.1016/j.jalz.2014.05.1757 PMC4672734 25533204 · DOI · Paper page

Cited by

Sorted by citations

Authors
Kamboh, M. I.
Affiliations
University of Pittsburgh (US)
Corresponding author
Kamboh, M. Ilyas
Venue
Current Genetic Medicine Reports
Published
2018-10-30
Volume
6
Issue
4
Pages
133-135
ISSN
2167-4876 (ISSN-L)
OpenAlex
W2898761798
Cited by
26
References
5
Citations by year
2026: 1 · 2025: 4 · 2024: 1 · 2022: 6 · 2021: 3 · 2020: 8 · 2019: 3
FWCI
2.41
Type
journal article
Language
en
Open access
Locations
  • Current Genetic Medicine Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute on Aging (R01AG041718, P50AG005133, R01AG030653)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
Alzheimer's disease, genetic susceptibility, familial Alzheimer's disease, sporadic Alzheimer's disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review